Prospects for treating osteoarthritis: enzyme–protein interactions regulating matrix metalloproteinase activity
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prospects for treating osteoarthritis: enzyme–protein interactions regulating matrix metalloproteinase activity
Authors
Keywords
-
Journal
Therapeutic Advances in Chronic Disease
Volume 3, Issue 5, Pages 219-229
Publisher
SAGE Publications
Online
2012-07-19
DOI
10.1177/2040622312454157
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer
- (2012) Subhankar Chakraborty et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Matrix Metalloproteinase Inhibitors: A Review on Bioanalytical Methods, Pharmacokinetics and Metabolism
- (2012) Xu Wang et al. CURRENT DRUG METABOLISM
- New Organ-Specific Pharmacological Strategies Interfering With Signaling Pathways In Inflammatory Disorders/Autoimmune Disorders
- (2012) Bradley A. Wisler et al. Current Signal Transduction Therapy
- Mammalian Siderophores, Siderophore-binding Lipocalins, and the Labile Iron Pool
- (2012) Colin Correnti et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- An Alternate Perspective on the Roles of TIMPs and MMPs in Pathology
- (2011) Craig S. Moore et al. AMERICAN JOURNAL OF PATHOLOGY
- Recent progress in understanding molecular mechanisms of cartilage degeneration during osteoarthritis
- (2011) Meina Wang et al. Annals of the New York Academy of Sciences
- Changes in subchondral bone early in the development of osteoarthritis
- (2011) S. C. Mastbergen et al. ARTHRITIS AND RHEUMATISM
- Neutrophil gelatinase-associated lipocalin in gastric carcinoma cells and its induction by TPA are controlled by C/EBPβ
- (2011) Ze-Peng Du et al. Biochemistry and Cell Biology
- Effects of Hylan G-F 20 supplementation on cartilage preservation detected by magnetic resonance imaging in osteoarthritis of the knee: a two-year single-blind clinical trial
- (2011) Yuanyuan Wang et al. BMC MUSCULOSKELETAL DISORDERS
- Lipocalin 2: A multifaceted modulator of human cancer
- (2011) Jiang Yang et al. CELL CYCLE
- New Hope for the Treatment of Osteoarthritis Through Selective Inhibition of MMP-13
- (2011) N.-G. Li et al. CURRENT MEDICINAL CHEMISTRY
- NGAL is a Precocious Marker of Therapeutic Response
- (2011) Valeria Cernaro et al. CURRENT PHARMACEUTICAL DESIGN
- Lipocalin 2 regulation and its complex role in inflammation and cancer
- (2011) Chen Li et al. CYTOKINE
- Immunohistochemical detection of a specific receptor for lipocalin2 (solute carrier family 22 member 17, SLC22A17) and its prognostic significance in endometrial carcinoma
- (2011) Tsutomu Miyamoto et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Emerging drugs for osteoarthritis
- (2011) Gloria L Matthews et al. EXPERT OPINION ON EMERGING DRUGS
- Discovery and Evaluation of a Non-Zn Chelating, Selective Matrix Metalloproteinase 13 (MMP-13) Inhibitor for Potential Intra-articular Treatment of Osteoarthritis
- (2011) Christian Gege et al. JOURNAL OF MEDICINAL CHEMISTRY
- Osteoarthritis year 2010 in review: pathomechanisms
- (2011) W.B. van den Berg OSTEOARTHRITIS AND CARTILAGE
- A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee
- (2011) Stanley B Cohen et al. ARTHRITIS RESEARCH & THERAPY
- Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthritis: a meta-analysis of clinical and radiographic remission
- (2010) B. Kuriya et al. ANNALS OF THE RHEUMATIC DISEASES
- New molecular targets for the treatment of osteoarthritis
- (2010) Maria José Alcaraz et al. BIOCHEMICAL PHARMACOLOGY
- Molecular Interactions of MMP-13 C-Terminal Domain with Chondrocyte Proteins
- (2010) Liang Zhang et al. CONNECTIVE TISSUE RESEARCH
- Disease Modifying Osteoarthritis Drugs: Facing Development Challenges and Choosing Molecular Targets
- (2010) Marie-Pierre Hellio Le Graverand-Gastineau CURRENT DRUG TARGETS
- Anticytokine Therapy for Osteoarthritis
- (2010) Charles J. Malemud DRUGS & AGING
- Hyaluronic Acid (Supartz®)
- (2010) Monique P. Curran DRUGS & AGING
- Induction of Neutrophil Gelatinase-associated Lipocalin Expression by Co-stimulation with Interleukin-17 and Tumor Necrosis Factor-α Is Controlled by IκB-ζ but neither by C/EBP-β nor C/EBP-δ
- (2010) Joachim R. Karlsen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Clinical and biochemical characteristics after intra-articular injection for the treatment of osteoarthritis of the knee: prospective randomized study of sodium hyaluronate and corticosteroid
- (2010) Masaki Shimizu et al. JOURNAL OF ORTHOPAEDIC SCIENCE
- The Discovery of Novel Experimental Therapies for Inflammatory Arthritis
- (2010) Charles J. Malemud MEDIATORS OF INFLAMMATION
- Role of proinflammatory cytokines in the pathophysiology of osteoarthritis
- (2010) Mohit Kapoor et al. Nature Reviews Rheumatology
- Expression levels and association of gelatinases MMP-2 and MMP-9 and collagenases MMP-1 and MMP-13 with VEGF in synovial fluid of patients with arthritis
- (2010) Kyoung Soo Kim et al. RHEUMATOLOGY INTERNATIONAL
- Hyaluronic Acid Viscosupplementation and Osteoarthritis
- (2009) Eric J. Strauss et al. AMERICAN JOURNAL OF SPORTS MEDICINE
- Activation of cartilage matrix metalloproteinases by activated protein C
- (2009) Miriam T. Jackson et al. ARTHRITIS AND RHEUMATISM
- Intraarticular injection of anakinra in osteoarthritis of the knee: A multicenter, randomized, double-blind, placebo-controlled study
- (2009) X. Chevalier et al. ARTHRITIS AND RHEUMATISM
- Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease
- (2009) Xeni Provatopoulou et al. BMC CANCER
- Targeting Matrix Metalloproteinases in Inflammatory Conditions
- (2009) A. Clutterbuck et al. CURRENT DRUG TARGETS
- Targeting JAK/STAT Signaling Pathway in Inflammatory Diseases
- (2009) Charles Malemud et al. Current Signal Transduction Therapy
- Novel selective MMP-13 inhibitors reduce collagen degradation in bovine articular and human osteoarthritis cartilage explants
- (2009) Dorothea Piecha et al. INFLAMMATION RESEARCH
- Neutrophil Gelatinase–Associated Lipocalin (NGAL) as a Marker of Kidney Damage
- (2008) Davide Bolignano et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- The Siderocalin/Enterobactin Interaction: A Link between Mammalian Immunity and Bacterial Iron Transport1
- (2008) Rebecca J. Abergel et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started